Artificial intelligence and advanced melanoma: treatment management implications
Artificial intelligence (AI), a field of research in which computers are applied to mimic
humans, is continuously expanding and influencing many aspects of our lives. From electric …
humans, is continuously expanding and influencing many aspects of our lives. From electric …
[HTML][HTML] Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review
LS Ter Maat, IAJ van Duin, SG Elias… - European Journal of …, 2022 - Elsevier
Background Checkpoint inhibition has radically improved the perspective for patients with
metastatic cancer, but predicting who will not respond with high certainty remains difficult …
metastatic cancer, but predicting who will not respond with high certainty remains difficult …
Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis
Importance Existing criteria to estimate the benefit of a therapy in patients with cancer rely
almost exclusively on tumor size, an approach that was not designed to estimate survival …
almost exclusively on tumor size, an approach that was not designed to estimate survival …
Precision medicine and melanoma: multi-omics approaches to monitoring the immunotherapy response
F Valenti, I Falcone, S Ungania, F Desiderio… - International journal of …, 2021 - mdpi.com
The treatment and management of patients with metastatic melanoma have evolved
considerably in the “era” of personalized medicine. Melanoma was one of the first solid …
considerably in the “era” of personalized medicine. Melanoma was one of the first solid …
CT based radiomic approach on first line pembrolizumab in lung cancer
Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy.
The aim of the study is to assess whether CT-derived texture parameters can predict overall …
The aim of the study is to assess whether CT-derived texture parameters can predict overall …
Exploring CT texture parameters as predictive and response imaging biomarkers of survival in patients with metastatic melanoma treated with PD-1 inhibitor …
A Guerrisi, M Russillo, E Loi, B Ganeshan… - Frontiers in …, 2021 - frontiersin.org
In the era of artificial intelligence and precision medicine, the use of quantitative imaging
methodological approaches could improve the cancer patient's therapeutic approaches …
methodological approaches could improve the cancer patient's therapeutic approaches …
Combination of whole-body baseline ct radiomics and clinical parameters to predict response and survival in a stage-iv melanoma cohort undergoing immunotherapy
Simple Summary The use of immunotherapeutic agents significantly improved stage-IV
melanoma patients' overall progression-free survival. To identify patients who do not benefit …
melanoma patients' overall progression-free survival. To identify patients who do not benefit …
Assessing immunotherapy with functional and molecular imaging and radiomics
R García-Figueiras, S Baleato-González, A Luna… - Radiographics, 2020 - pubs.rsna.org
Immunotherapy is changing the treatment paradigm for cancer and has introduced new
challenges in medical imaging. Because not all patients benefit from immunotherapy …
challenges in medical imaging. Because not all patients benefit from immunotherapy …
FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
A Flaus, V Habouzit, N De Leiris, JP Vuillez… - Scientific reports, 2021 - nature.com
Our aim was to analyse whether biomarkers extracted from baseline 18F-FDG PET before
anti-PD1 treatment contribute to prognostic survival information for early risk stratification in …
anti-PD1 treatment contribute to prognostic survival information for early risk stratification in …
[HTML][HTML] Can delta radiomics improve the prediction of best overall response, progression-free survival, and overall survival of melanoma patients treated with immune …
F Peisen, A Gerken, A Hering, I Dahm, K Nikolaou… - Cancers, 2024 - mdpi.com
Simple Summary The incidence of metastatic melanoma is rising, making it imperative to
identify patients who do not benefit from immunotherapy. This study aimed to develop a …
identify patients who do not benefit from immunotherapy. This study aimed to develop a …